Tech Company Financing Transactions

Accord Biomaterials Funding Round

ForgePoint Capital, Grayhawk Venture Partners and INVESCO Private Capital joined a $12.8 million Series C capital raise for Accord Biomaterials. The round was announced on 7/2/2007.

Transaction Overview

Announced On
7/2/2007
Transaction Type
Venture Equity
Amount
$12,750,000
Round
Series C
Proceeds Purpose
"The new, significant investment by Trident Capital strengthens our position in the marketplace by enabling us to more rapidly introduce new, exciting services and gain additional share of the unbanked consumer market. This is clearly a highly-attractive market segment, and one where we are already recognized as the leader," said Tim Coltrell, CEO of AccountNow.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3550 W. Liberty Rd. 3
Ann Arbor, MI 48103
USA
Email Address
Overview
The former website of Accord Biomaterials, Inc.
Profile
Accord Biomaterials LinkedIn Company Profile
Social Media
Accord Biomaterials Company Twitter Account
Company News
Accord Biomaterials News
Facebook
Accord Biomaterials on Facebook
YouTube
Accord Biomaterials on YouTube

Management Team

Title
Name
Email & Social
President
Kris Aalto
  Kris Aalto LinkedIn Profile  Kris Aalto Twitter Account  Kris Aalto News  Kris Aalto on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2007: Prism Pharmaceuticals venture capital transaction
Next: 7/2/2007: newScale venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary